Celltrion Inc (068270)

Seoul
270,500.00
+5,500.00(+2.08%)
  • Volume:
    565,243
  • Bid/Ask:
    270,000.00/270,500.00
  • Day's Range:
    261,500.00 - 271,500.00

068270 Overview

Prev. Close
265,000
Day's Range
261,500 - 271,500
Revenue
1.85T
Open
265,000
52 wk Range
201,961 - 395,590
EPS
3,789.26
Volume
565,243
Market Cap
36.49T
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
241,386
P/E Ratio
69.93
Beta
0.83
1-Year Change
25.96%
Shares Outstanding
136,466,252
Next Earnings Date
May 12, 2021
What is your sentiment on Celltrion Inc?
or
Market is currently closed. Voting is open during market hours.

Celltrion Inc News

Celltrion Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralBuy

Celltrion Inc Company Profile

Celltrion Inc Company Profile

Employees
1074

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Read More
  • CELLTRION!!COVID -19 TREATMENT!! GOGO TO THE MOON!
    0
    • amazing stock
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.